Association between Pretreatment Serum High-density Lipoprotein Cholesterol and Treatment Outcomes in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy: Findings from a Randomised Trial
Conclusions: The pretreatment serum level of HDL-C was an independent prognostic factor for patients with locoregionally advanced nasopharyngeal carcinoma who were treated with chemoradiotherapy.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Cheng-Tao Wang, Ming-Yuan Chen, Xiang Guo, Ling Guo, Hao-Yuan Mo, Chao-Nan Qian, Bi-Xiu Wen, Ming-Huang Hong, Pei-Yu Huang Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Cholesterol | Clinical Trials | Nasopharyngeal Cancer